Kidney function predicts new-onset cardiorenal events and mortality in primary aldosteronism: approach of the 2021 race-free eGFR equation-Reference-Cited by-同舟云学术

Kidney function predicts new-onset cardiorenal events and mortality in primary aldosteronism: approach of the 2021 race-free eGFR equation

Published:2023-09-16 Issue:1 Volume:47 Page:233-244
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

Lai Chun-Fu,Lin Yen-Hung,Huang Kuo-How,Chueh Jeff S.,Wu Vin-Cent,Lai Tai-Shuan,Yang Shao-Yu,Liu Kao-Lang,Chang Chin-Chen,Lee Bo-Ching,Wang Shuo-Meng,Lin Po-Chih,Hung Chi-Sheng,Lin Lian-Yu,Liao Shih-Cheng,Lu Ching-Chu,Chan Chieh-Kai,Er Leay-Kiaw,Hu Ya-Hui,Wu Che-Hsiung,Tsai Yao-Chou,Chen Zheng-Wei,Pan Chien-Ting,Liao Che-Wei,Tsai Cheng-Hsuan,Chang Yi-Yao,Ho Chen-Hsun,Huang Wei-Chieh,Chen Ying-Ying,

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Link

https://www.nature.com/articles/s41440-023-01400-0.pdf

Reference58 articles.

1. Takeda Y, Karashima S, Yoneda T. Primary aldosteronism, diagnosis and treatment in Japan. Rev Endocr Metab Disord. 2011;12:21–5.

2. Huang KH, Yu CC, Hu YH, Chang CC, Chan CK, Liao SC, et al. Targeted treatment of primary aldosteronism - the consensus of Taiwan Society of Aldosteronism. J Formos Med Assoc. 2019;118:72–82.

3. Xu Z, Yang J, Hu J, Song Y, He W, Luo T, et al. Primary aldosteronism in patients in China with recently detected hypertension. J Am Coll Cardiol. 2020;75:1913–22.

4. Yoon M, Hong N, Ha J, Lee CJ, Ku CR, Rhee Y, et al. Prevalence and clinical characteristics of primary aldosteronism in a tertiary-care center in Korea. Hypertens Res. 2022;45:1418–29.

5. Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69:1811–20.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Re: comment from Ladak et al. to JH-D-23-00692, entitled ‘Analyzing eGFR-Dip after medical target therapy in primary aldosteronism’;Journal of Hypertension;2024-01-04

2. No “U-shaped” associations of estimated glomerular filtration rate with adverse cardiovascular outcomes in patients with primary aldosteronism;Hypertension Research;2023-11-09